EU gives CE mark approval to next generation Enroute TNS for artery repair -Silk Road Medical
Silk Road Medical announced CE Mark approval for its next generation Enroute Transcarotid Neuroprotection System. The Enroute NPS remains the only device specifically designed and indicated for TransCarotid Artery Revascularization (TCAR), a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.
The Enroute NPS allows the physician to directly access the common carotid artery in the neck and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting Silk Road's Enroute Transcarotid Stent. The first TCAR procedures with the new Enroute NPS were recently performed in European hospitals.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
2 mins